1 Current & New treatment strategies to address CV Risk.

Slides:

Advertisements

Similar presentations

BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.

Advertisements

The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.

JNC 8 Guidelines….

Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.

CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.

Hypertension Guidelines 2014

BLOOD PRESSURE Systolic Diastolic.

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

JNC 8 GUIDELINES Cardiologist , AMIRI HOSPITAL, MOH , Kuwait.

Hypertension in the Elderly ACCF/AHA 2011 Expert Consensus Document Developed in collaboration with the American Academy of Neurology, Association of Black.

Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.

Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.

The concept of Diabetes & CV risk: A lifetime risk challenge

Type 2 diabetes and high blood pressure How explosive is the cocktail?

Specific guidelines on the use of arterial measurements Jiguang WANG, MD, PhD Professor of Cardiovascular Medicine The Shanghai Institute of Hypertension,

Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.

L’Ipertensione Arteriosa nel Paziente Diabetico: Nuovi Target Terapeutici Dr. Vittorio Emanuele Scalea

1 The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence.

QUALITY USE OF CARDIOVASCULAR MEDICATION Dr Mark Abelson.

Improving the Care of the Hypertensive Patient: US Perspective William Cushman, MD Professor, Preventive Medicine and Medicine University of Tennessee.

William B. Kannel, MD, FACC Former Director, Framingham Heart Study

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ALLHAT study overview Double-blind, randomized trial to determine whether.

DR. IDOWU AKOLADE EDM DIVISION LUTH

1 1 Individualized Therapy forHypertension Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh

Casablanca, le 30 Avril 2011 MEDITERANEAN GROUP FOR STUDY DIABETES.

Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.

Daily Dilemmas in Hypertension Management. Objectives Review the impact of hypertension on society Review the impact of hypertension on society Review.

1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.

Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal

 Update on Hypertension Troy L. Randle, DO, FACC, FACOI.

Systolic hypertension not an isolated problem Michael Weber, MD Professor of Medicine Associate Dean Downstate College of Medicine State University of.

Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) 2014 evidence-based guidelines for the management of high blood.

Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.

Blood pressure control in primary health care WORKSHOP

DION GALLANT, MD PRIMARY CARE SERVICE LINE MEDICAL DIRECTOR PRESBYTERIAN MEDICAL GROUP JNC 8.

10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.

Avoiding Cardiovascular Events through COMbination Therapy in Patients LIving with Systolic Hypertension The First Outcomes Trial of Initial Therapy With.

UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,

7/27/2006 Outcomes in Hypertensive Black and Nonblack Patients Treated with Chlorthalidone, Amlodipine, and Lisinopril* * Wright JT, Dunn JK, Cutler JA.

Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.

PHARMACOTHERAPY OF HYPERTENSION Based on New Guidelines Fariborz Nikaeen; MD Interventional cardiologist 2 november 2015.

MIAMI: MIRECC Initiative on Antipsychotic Management Improvement Metabolic Monitoring and Management of Antipsychotic Medication.

JNC 7 blood pressure classification in adults aged ≥18 years BP Classification SBP (mm HG) DBP (mm HG) Normal

VBWG Growth in heart disease, 2000–2050 Deaths Population Foot DK et al. J Am Coll Cardiol. 2000;35:

1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.

JNC 7 血壓分期. 血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.

2007 Hypertension as a Public Health Risk January, 2007.

Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.

Treatment of Hypertension in Adults With Diabetes DR AMAL HARFOUSH.

April 22, 2016 Connie Tien Daniel Kim Jeffrey Hughes Michelle Di Fiore

Antonio Coca, MD, PhD, FRCP, FESC

Blood Pressure and Lipid Trials: Rationale, Importance and Design

David Antecol, M.D., FACC, FASH, FRCP(C) Specialist in Clinical Hypertension (American Society of Hypertension) Disclosures: None.

Hypertension guidelines What’s all the controversy about 2015

JNC VIII Hypertension.

Hypertension JNC VIII Guidelines.

Hypertension Guidelines-JNC 8

What’s New in the 2013 ESC/ESH Hypertension Guideline

Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.

Achieving the Clinical Potential of RAAS Blockade

Проценка на кардиоваскуларен ризик и препораки за третман

Managing Hard-To-Treat Hypertension: What Every Physician Should Know

Table of Contents Why Do We Treat Hypertension? Recommendation 5

Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010

Primary Hypertension Max C. Reif, M.D.

Managing Blood Pressure

JNC Evidence-Based Guideline for the Management of

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

JNC Evidence-Based Guideline for the Management of

An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61

Presentation transcript:

1 Current & New treatment strategies to address CV Risk

Age (yrs) Evolution of Atherosclerosis Clinical Events GeneticEnvironmental

Atherosclerosis: ‘Investing in your Arteries ’ Early Intervention for Lifetime Risk management

Framingham Heart Study:Lifetime Ri sk Adjusted Cumulative Incidence 50% 39% 27 % Attained Age % 50% 46% 36% 5% % ≥2 Major RFs 1 Major RF ≥ Elevated RF ≥ Not Elevated RF All Optimal RFs Men Women Lloyd-Jones Circ. 2006; 113:

Age and CV Risk in Diabetes Booth Lancet 2006; 368: Women Women with diabetes Women without diabetes Age (years) Men Men with diabetes Men without diabetes Age (years)

Current Guidelines Based on Short term Absolute Risk

Individuals with low 10-year but high lifetime risk have a greater subclinical disease burden and greater incidence of atherosclerotic progression compared with individuals with low 10-year and low lifetime risk, even at younger ages New Guidelines

Not at Goal BP (<140/90 mm Hg) (<130/80 mm Hg for those with diabetes or chronic kidney disease) Initial Drug Choices Drug(s) for the compelling indications Other antihypertensive drugs (diuretics, ACEI, ARB, BB, CCB) as needed Drug(s) for the compelling indications Other antihypertensive drugs (diuretics, ACEI, ARB, BB, CCB) as needed With Compelling Indications Lifestyle Modifications Stage 2 Hypertension (SBP  160 or DBP  100 mm Hg) 2-drug combination for most (usually thiazide-type diuretic and ACEI, or ARB, or BB, or CCB) Stage 1 Hypertension (SBP or DBP mm Hg) Thiazide-type diuretics for most May consider ACEI, ARB, BB, CCB, or combination Without Compelling Indications JNC 7 Algorithm for Treatment of Hypertension Chobanian et al. JAMA. 2003;289:

ESH  ESC and JNC 7 Guidelines Recommend Target BP Goals of <140/90 mmHg for Uncomplicated Hypertension and <130/80 mmHg for Complicated Hypertension 1 Type of hypertensionBP goal (mmHg) Uncomplicated<140/90 Complicated Diabetes mellitus<130/80 Kidney disease<130/80* Other high risk (stroke, myocardial infarction) <130/80 1. Task Force of ESH–ESC. J Hypertens 2007;25:1105  Chobanian et al. Hypertension 2003;42:1206–52 *Lower if proteinuria is >1 g/day

Blood Pressure Targets UncomplicatedDMCRF US (2003 )< 140/90 < 130/80 < 130/80 Europe (2007)< 140/90 < 130/80 < 130/80 WHO/ISH (2004)SBP < 140 < 130/80 < 130/80 UK (2004)< 140/85 < 130/80 < 130/80 China (2005)< 140/90 < 130/80 < 130/80